Publicaciones (60) Publicaciones de RENE RODRIGUEZ GONZALEZ Ver datos de investigación referenciados.

2024

  1. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma

    eBioMedicine, Vol. 102

2023

  1. ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

    Nature Communications, Vol. 14, Núm. 1

  2. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling

    Biomedicine and Pharmacotherapy, Vol. 162

  3. Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma

    Redox Biology, Vol. 62

  4. Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells

    Free Radical Biology and Medicine, Vol. 209, pp. 127-134

  5. Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer

    Biomedicines, Vol. 11, Núm. 1

  6. Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways

    Biomedicine and Pharmacotherapy, Vol. 161

2022

  1. Addressing Doxorubicin Resistance in Bone Sarcomas using Novel Drug‐Resistant Models

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  2. Proof of concept for the use of trained sniffer dogs to detect osteosarcoma

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Cancer stem cells and clonal evolution in bone sarcomas

    Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside (Elsevier), pp. 371-391

  2. Cancer stem cells as a source of drug resistance in bone sarcomas

    Journal of Clinical Medicine, Vol. 10, Núm. 12

  3. Mithramycin delivery systems to develop effective therapies in sarcomas

    Journal of Nanobiotechnology, Vol. 19, Núm. 1

  4. Nano-encapsulation of mithramycin in transfersomes and polymeric micelles for the treatment of sarcomas

    Journal of Clinical Medicine, Vol. 10, Núm. 7

2020

  1. GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β

    Cell Death and Disease, Vol. 11, Núm. 11

  2. Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL

    Blood, Vol. 136, Núm. 3, pp. 313-327

  3. Sarcoma treatment in the era of molecular medicine

    EMBO Molecular Medicine, Vol. 12, Núm. 11

  4. Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications

    Cancers, Vol. 12, Núm. 4

2019

  1. New chondrosarcoma cell lines with preserved stem cell properties to study the genomic drift during in vitro/in vivo growth

    Journal of Clinical Medicine, Vol. 8, Núm. 4

  2. Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma

    Scientific Reports, Vol. 9, Núm. 1

  3. Sarcoma Stem Cell Heterogeneity

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 95-118